POMDOCTOR LIMITED: valuation

POMNASDAQConsumer cyclical · Retail-Miscellaneous Retail

Price

$1.62

November 13, 2026

DCF calculator

What Ploutos Investor adds for POMDOCTOR

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
  • The debt we can read is far below what the company's own annual report says falls due over the coming years, so most of its borrowing is in figures we cannot read. We leave out the debt, net cash, enterprise value and the multiples built on them.

Valuation today

What the market pays for the company's earnings, cash flow, book value and revenue at $1.62 (November 13, 2026), beside the median of its past fiscal years.

Sorry, we do not have enough data

for POMDOCTOR's valuation today

Why?

Each year's figuresPOMDOCTOR's filings

DCF calculator

What is POMDOCTOR worth on your own assumptions?

The DCF calculator opens with the company's figures already filled in from its filings. You set how fast its cash flow grows and the return you ask for, and see the value those assumptions give.

Free cash flow, 12 months
-$21M
Net cash
–
Shares
58.08M
FCF, 5-year average a year
–
Revenue, 5-year average a year
+14.5%
Price
$1.62
Value POM

The full analysis

What do POMDOCTOR's filings show?

The multiples say what the market pays for POMDOCTOR. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about POM's valuation

Didn't find what you were looking for?

Ask us
How do I work out what POM is worth?

With the DCF calculator: it opens with POMDOCTOR's figures from its filings, you enter your assumptions for growth and the return you ask for, and see the value they give. The company pages give no price target of their own. A full analysis gives a fair-value range, which is an estimate, not a target.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. The estimated fair value, where shown, is our estimate, labelled as one: not a fact, not a score and not a recommendation to buy or sell.